| |
| |
|
| Insider
Information: |
Azelby Robert |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
25,006 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$546,398 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,006 |
|
|
| Total
Value |
$546,398 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Juno Therapeutics, Inc. |
JUNO |
EVP & Chief Commercial... |
2018-03-05 |
0 |
2015-11-01 |
0 |
Premium* |
|
|
Immunomedics Inc |
IMMU |
Director |
2020-06-18 |
3,718 |
2020-06-18 |
0 |
Premium* |
|
|
ADC Therapeutics Sa |
ADCT |
Director |
2024-01-02 |
20,000 |
|
0 |
Premium* |
|
|
Cardinal Health Inc |
CAH |
Director |
2024-03-15 |
1,288 |
2024-03-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAH |
Cardinal Health Inc |
Director |
– • – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,288 |
1,288 |
0 |
- |
|
| ADCT |
ADC Therapeutics Sa |
Director |
– • – |
2024-01-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
% |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
3,718 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-03-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(89,612) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-12 |
4/A |
AS |
$85.55 |
$355,802 |
D/D |
(4,159) |
89,612 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-12 |
4 |
AS |
$85.55 |
$355,631 |
D/D |
(4,157) |
89,614 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-08 |
4 |
OE |
$20.76 |
$76,376 |
D/D |
3,497 |
97,268 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-08 |
4 |
AS |
$85.77 |
$299,938 |
D/D |
(3,497) |
93,771 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-07 |
4 |
D |
$85.49 |
$230,823 |
D/D |
(2,700) |
93,771 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-01 |
4 |
AS |
$85.78 |
$357,445 |
D/D |
(4,167) |
96,471 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-02-01 |
4 |
OE |
$51.76 |
$215,684 |
D/D |
4,167 |
100,638 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,639 |
96,471 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-01-22 |
4 |
AS |
$86.25 |
$8,843,989 |
D/D |
(102,539) |
70,832 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-01-22 |
4 |
OE |
$51.76 |
$5,307,419 |
D/D |
102,539 |
173,371 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-01-17 |
4 |
AS |
$68.10 |
$1,998,603 |
D/D |
(29,131) |
70,832 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2018-01-17 |
4 |
OE |
$20.76 |
$616,076 |
D/D |
29,131 |
99,963 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-12-18 |
4 |
AS |
$44.96 |
$81,647 |
D/D |
(1,816) |
70,832 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-11-08 |
4 |
D |
$55.98 |
$38,290 |
D/D |
(684) |
72,648 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-11-02 |
4 |
AS |
$54.95 |
$366,297 |
D/D |
(6,666) |
73,332 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-11-02 |
4 |
OE |
$25.29 |
$168,583 |
D/D |
6,666 |
79,998 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
35,893 |
73,332 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-09-13 |
4 |
AS |
$44.95 |
$577,608 |
D/D |
(12,850) |
37,439 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-08-29 |
4 |
AS |
$39.95 |
$514,117 |
D/D |
(12,869) |
50,289 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
27,439 |
63,158 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
EVP & Chief Commercial Officer |
• – – |
2016-11-10 |
4 |
AS |
$24.14 |
$311,848 |
D/D |
(12,921) |
35,719 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
